Cancel
Alyssa Wyant
Chief Regulatory & Quality Officer
@
Praxis Precision Medicines
About Alyssa Wyant
Alyssa Wyant is the Chief Regulatory & Quality Officer with over 20 years of experience in regulatory affairs, specializing in CNS and rare diseases.
Known information
Alyssa Wyant currently serves as the Chief Regulatory & Quality Officer, a role she assumed after her tenure as Senior Vice President of Regulatory and Quality from September 2020 to November 2021. Prior to this, she worked at EryDel S.p.A as Senior Vice President, Regulatory Affairs from January 2019 to August 2020. Wyant has also held senior leadership positions at Edge Therapeutics, Inc. and PTC Therapeutics, Inc., contributing significantly to the field of regulatory affairs. With over two decades of experience, she has successfully led the creation and implementation of global strategies for the development, registration, and post-approval activities of numerous approved products, particularly in the areas of CNS and rare diseases. Wyant holds a B.S. in cell and molecular biology from the University of Washington.
About Praxis Precision Medicines
Praxis Precision Medicines is a biotechnology company based in Boston, Massachusetts, specializing in developing precision therapies for central nervous system disorders using human genetics and translational tools.
Report inaccurate information
